摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,4R,5R)-2-Allyl-3,4-bis-benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-carbaldehyde | 429675-57-0

中文名称
——
中文别名
——
英文名称
(2R,3S,4R,5R)-2-Allyl-3,4-bis-benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-carbaldehyde
英文别名
(2R,3S,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-2-prop-2-enyloxolane-2-carbaldehyde
(2R,3S,4R,5R)-2-Allyl-3,4-bis-benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-carbaldehyde化学式
CAS
429675-57-0
化学式
C30H32O5
mdl
——
分子量
472.581
InChiKey
UHBIISZWXMGCTL-XAZDILKDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    35
  • 可旋转键数:
    13
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Carbohydrate-Based Scaffolds for the Generation of Sortiments of Bioactive Compounds
    作者:Francesco Peri、Laura Cipolla、Eleonora Forni、Francesco Nicotra
    DOI:10.1007/s007060200016
    日期:2002.4.1
     The polyfunctionality and conformational rigidity of carbohydrates make this class of compounds ideal scaffolds for the production of sortiments1 of bioactive compounds. Examples of carbohydrate-derived peptidomimetics of biological interest, such as somatostatin agonists and integrin antagonists, are presented. In order to have access to solid phase supported sortiments of compounds, orthogonally
     碳水化合物的多功能性和构象刚度使这类化合物成为生产生物活性化合物的理想选择1。提供了具有生物学意义的碳水化合物衍生的拟肽的实例,例如生长抑素激动剂和整联蛋白拮抗剂。为了获得固相支持的化合物,将正交保护或未保护的碳水化合物与聚合物连接,并使用不同的区域选择性策略在固相中反应。原始的双环和三环缩水甘油骨架很容易从天然糖(例如 D- 阿拉伯糖 和 D)中获得 -果糖。操纵这些构象封闭的化合物可得到不同的基于碳水化合物的衍生物,其中叠氮酸是β-转肽模拟物的有用前体。
  • Fructose-fused γ-butyrolactones and lactams, synthesis and biological evaluation as GABA receptor ligands
    作者:Ana C. Araújo、Francesco Nicotra、Barbara Costa、Gabriella Giagnoni、Laura Cipolla
    DOI:10.1016/j.carres.2008.03.013
    日期:2008.7
    We describe the synthesis of sugar-fused beta-disubstituted gamma-butyrolactones, gamma-butyrolactams and a lipophilic beta-disubstituted GABA analogue as potential GABA receptor ligands, where the pharmacophore is engineered into the carbohydrate scaffold in the form of a C-fructoside. The products were characterized for receptor binding studies of GABA(A) receptors. (c) 2008 Elsevier Ltd. All rights reserved.
  • Polycyclic scaffolds from fructose
    作者:Eleonora Forni、Laura Cipolla、Enrico Caneva、Barbara La Ferla、Francesco Peri、Francesco Nicotra
    DOI:10.1016/s0040-4039(01)02393-0
    日期:2002.2
    Iodocyclisation of polybenzylated allyl alpha-C-fructofuranoside 1 afforded the bicyclic iodoether 2 through debenzylation at C-1: treatment of 2 with zinc and acetic acid restored the all tic group with concomitant deprotection of the hydroxyl group ;at C-1, which as oxidised to the corresponding aldehyde 4. Reaction of 4 with vinylmagnesium bromide afforded diene 5, whose double bonds were reacted regioselectively in order to obtain, upon iodocylisation under different experimental conditions. bicycles 6 or 7, or tricycle 8. (C) 2002 Elsevier Science Ltd. All rights reserve.
  • Synthesis and Conformational Analysis of Fructose-Derived Scaffolds: Molecular Diversity from a Single Molecule
    作者:Laura Cipolla、Eleonora Forni、Jesus Jiménez-Barbero、Francesco Nicotra
    DOI:10.1002/1521-3765(20020902)8:17<3976::aid-chem3976>3.0.co;2-7
    日期:2002.9.2
    and tricyclic compounds were synthesized starting from fructose. The different hydroxyl groups present in fructose were exploited in the formation of a number of conformationally constrained sugar-based scaffolds, including azido acids. Introduction of an azido group and carboxy terminus into different bicyclic iodo ethers, allowed the synthesis of different conformationally constrained azido acids.
    从果糖开始合成双环和三环化合物。果糖中存在的不同羟基被用于形成许多构象受限的糖基支架,包括叠氮酸。将叠氮基和羧基末端引入不同的双环碘醚中,可以合成不同的构象约束叠氮酸。通过分子力学协助的NMR实验对化合物10、11、17和20进行构象分析,可以确定相关官能团之间的距离,即叠氮基和羧基官能团。
查看更多